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PATIENT VIGNETTE
We report the case of an 86-year-old female who described 15-years of sharp, stabbing pain that
radiated down the distribution of the second and third divisions of her right trigeminal nerve. She
described two trigger points, one on her right cheek and a second intra-oral trigger. Her symptoms
were often triggered by eating and she had begun to loose weight secondary to the pain. She denied
having any baseline pain between the episodes of lancinating pain. She denied any contralateral pain,
dysasthetic pain or any burning pain sensation. She denied any pain along the first trigeminal division
and did not recently undergo any dental work or have a history of dental carries. Her symptoms had
been initially well controlled with Carbamazepine 200 mg BID, but had recently worsened despite
increasing the dosage to 600 mg BID when she started to develop medication-related side effects.
Her past medical history was unremarkable, and on examination she was neurologically intact. Her
brain magnetic resonance imaging (MRI) showed no masses or gross abnormalities, and she was
diagnosed with trigeminal neuralgia.
Neurosurgical intervention was pursued because the patient was refractory to medical therapy and
had worsening symptoms. Non-invasive Gamma Knife radiosurgery was recommended because
of the patient’s surgical risk profile and preference for a non-invasive procedure. Using Leksell
stereotactic frame, a stereotactic MRI dataset was generated with a gradient echo and CISS sequence.
On the Leksell gamma planning workstation we identified the right trigeminal nerve and prescribed
90 Gy to the 100% isodose line using a single 4-mm shot such that the 20% isodose line was tangential
to the brainstem. The patient tolerated the procedure well and reported complete resolution of her
symptoms at one-month follow-up.

2

DISCUSSION
For patients complaining of facial pain, the differential diagnosis is broad. It includes dental
abnormalities, such as caries, root abscesses,
and broken teeth; temporomandibular joint
pain; eye pain due to glaucoma, orbital cellulitis,
or trauma; facial trauma including bony fractures; tumors of the facial bones or infiltrating
the trigeminal nerve; giant cell arteritis; trigeminal autonomic cephalgias, such as cluster
headache and paroxysmal hemicrania; primary
headache syndromes including migraine and
tension types; postherpatic neuralgia; systemic
autoimmune disorders including lupus erythematosis; and other structural pathology, such as
cerebellopontine angle tumors and cysts.1
The International Headache Society (ihsclassification.org) defines classical trigeminal
neuralgia as follows: (1) Paroxysmal attacks of
pain lasting from a fraction of a second to two
minutes, affecting one or more divisions of the
trigeminal nerve; (2) Pain has at least one of
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the diagnosis and the decision for potential
surgical exploration remains a purely clinical
diagnosis irrespective of MRI presence of vascular compression.

HISTORICAL CONTEXT
The earliest reported case of trigeminal
neuralgia was Johannes Laurentis Bausch
(1605-1665), physician and president of the
Imperial Leopoldian Academy of Natural
Sciences. Bausch himself suffered from severe
trigeminal neuralgia, and the course of his
illness was detailed in his eulogy, which was
published posthumously by the Academy.4
Next, John Locke (1632-1704), physician and
famed philosopher, was summoned to visit the
Countess of Northumberland (wife of an English Ambassador), who suffered from crippling
trigeminal neuralgia. Locke recorded the case.4.
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the following characteristics: intense, sharp,
superficial or stabbing; precipitated from trigger areas or by trigger factors; and (3) Attacks
are stereotyped in the individual patients.
Additionally, there can be no clinically evident
neurological deficit, and the symptoms must not
be attributed to another disorder. In contrast,
atypical trigeminal neuralgia refers to symptoms
that are not paroxysmal, have associated chronic
pain, and/or a dysasthetic quality.

The French term for trigeminal neuralgia, tic
douloureux, was coined by surgeon Nicolaus
Andre (born 1704), who reported a case series
of five “tic” patients and, amazingly, practiced
trigeminal nerve ablation by applying caustic
substances through infraorbital foramina.4
John Hunter (1728-1793), an English anatomist
and physician, further narrowed in on the neurological basis for trigeminal neuralgia, stating
that:
There is one disease of the jaw which seems in
reality to have no connection with the teeth, but
of which the teeth are generally suspected to be
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the cause...I have known cases of this kind where
all the teeth of the affected side of the jaw have
been drawn out, and the pain has continued in
the jaw...Hence it should appear that the pain
in question does not arise from any disease in
the part, but it is entirely a nervous affection.4
Sir Charles Bell (1774-1842), famed Scottish
neuroanatomist, characterized the separate
functions of the trigeminal (V) and facial (VII)
nerves. Bell was the first to localize trigeminal
neuralgia to the trigeminal (V) nerve.1
Armed with this neuroanatomical knowledge,
surgeons began to explore how they might
treat this disorder. Harvey Cushing (18691939) pioneered a temporal fossa approach
beneath the middle meningeal artery, aiming
to completely extirpate the trigeminal ganglion.
Cushing later shifted to isolated sensory root
avulsion to spare motor function.5 Walter
Dandy (1886-1946) performed trigeminal root
neurotomies via a posterior fossa approach and
noted that “The [trigeminal nerve] sensory root
is frequently indented, lifted up, or bent at an
angle by the artery...This I believe is the cause
of tic douloureux”.6

More recently, Burchiel and colleagues2 developed a simplified framework for defining and
classifying trigeminal neuralgia (Table 1).
Importantly, trigeminal neuralgia traditionally
referred to as classical-type is redefined as TN1,
while idiopathic facial pain that is aching, throbbing, or burning for more than 50% of the time
(constant pain) is termed TN2. This distinction
between shock-like (TN1) and constant (TN2)
pain is the most significant predictor of longterm success after treatment.3
Preoperative MRI is useful to rule out any other
potential pathological etiologies such as tumor
or demyelinating disease. More advanced MR
imaging can identify the presence of vascular
compression at the root entry zone, which
can aid pre-operative planning. Nevertheless,
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More recently, Peter Jannetta, an American (and
Pennsylvanian!) neurosurgeon, established
open surgical microvascular decompression of
the trigeminal nerve as an effective procedure
for treating trigeminal neuralgia7 (discussed
below). Lars Leksell (1907-1986), Swedish neurosurgeon and inventor, famous for stating that
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Table 1. Burchiel definition and classification of trigeminal neuralgia (2)
Diagnostic Classification

Defining Symptomatology

Idiopathic
TN1

Sharp, shooting, electrical shock-like, episodic
pain

TN2

Aching, throbbing, burning, >50% constant pain

Trigeminal Injury
Neuropathic Pain

Unintentional (facial trauma; oral op; ear, nose,
& throat op; skull base op; posterior fossa op; or
stroke)

Deafferentation Pain

Intentional (neurectomy, gangliolysis, rhizotomy,
nucleotomy, tractotomy, or other denervating
procedure)

Symptomatic

Associated with multiple sclerosis

Postherpetic

Resulting from an outbreak of facial herpes zoster

Atypical Facial Pain

Somatoform pain disorder

“tools used by the surgeon must be adapted to
the task and where the human brain is concerned, no tool can be too refined,” invented
Gamma Knife Radiosurgery, which has since
been used to introduce radiosurgical lesions
of the trigeminal nerve to non-invasively
treat trigeminal neuralgia (discussed below).
Indeed, today’s multimodality armamentarium
for treating trigeminal neuralgia is broad.

PATHOGENESIS
Our understanding of the pathogenesis of
trigeminal neuralgia continues to evolve. The
leading explanation involves trigeminal nerve
root compression that causes demyelination.
Multiple different anatomical variants (classically the superior cerebellar artery) may
cause arterial and/or venous compression of
the trigeminal nerve root, usually within a few
millimeters of its entry into the brainstem.8
Pathological analyses demonstrate a focal
zone of chronic demyelination immediately
beneath the region of nerve indentation and
limited to the immediate vicinity of the point
of vascular indentation.9
In turn, this demyelination causes ectopic
(erratic) impulses and ephaptic (indirect)
cross-firing between nerve fibers. Experimental evidence from a model of purposefully
demyelinated nerve fibers in cat dorsal spinal
cord white matter demonstrates spontaneous,
ectopic activity.10 Ephaptic coupling refers to
the indirect firing that occurs between neural
fibers through extracellular electrical fields,
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as opposed to direct synaptic transmission.
Ephaptic coupling has been experimentally
demonstrated between immediately adjacent
non-myelinated axons.11
Abnormal ectopic and ephaptic electrical
impulses may lead to the development of
clinical pain hypersensitivity. Neuronal
plasticity is believed to be the underlying
cause of hypersensitivity phenomena including allodynia, hyperalgesia, and trigeminal
neuralgia.12
Knowledge of pathogenesis can directly
inform treatment approaches. Structural
nerve root compression can be addressed with
surgical decompression. Abnormal neuronal
firing can be addressed with medications such
as Carbamazepine, which stabilize neuronal
ion channels, reducing neuronal excitability.
Finally, hypersensitivity mediated by misdirected neuronal plasticity can be addressed
with ablative techniques directed to the nerve
itself.

TREATMENTS
Medical therapy for trigeminal neuralgia
includes anticonvulsant drugs. In 1963
Carbamazepine’s efficacy in treating this disorder was first demonstrated by Sigfrid Blom.13
Carbamazepine stabilizes inactivated voltagegated sodium channels, down-regulating
cellular excitability. It remains the first-line
drug of choice today. Alternative medications
include Oxcarbazepine, Baclofen, Gabapentin,
Lamotrigine, and Pimozide.

When medical therapy fails, surgical therapy
may be indicated. Surgical therapy for trigeminal neuralgia consists of two broad categories,
microvascular decompression, and ablative
procedures. Microvascular decompression
usually entails a retrosigmoid approach to the
upper cerebellopontine angle and identification
of the offending vessel causing nerve decompression. The most frequently identified culprit
is a superior cerebellar artery loop which, once
freed by sharp dissection, can be mobilized
away from the nerve and kept separated from
the nerve with a piece of shredded Teflon felt.14
Ablative procedures include rhizotomy (nerve
obliteration) and radiosurgery. Rhizotomy is
a percutaneous procedure, whereby a cannula
is passed through the foramen ovale and the
sensory component of the trigeminal nerve
is destroyed by radiofrequency thermocoagulation, mechanical balloons (e.g., Fogarty
catheter), or neurotoxic chemicals (e.g., glycerol). Radiosurgery utilizes Gamma Knife to
stereotactically direct conformal, high-dose
radiation to the cisternal portion of the trigeminal nerve. The procedure involves placement of
a head frame, which allows for the acquisition
of a stereotactic MRI scan to accurately identify
the nerve and safely target the radiation dose.
While medical therapy is generally accepted as
the first-line treatment for trigeminal neuralgia,
best surgical practice for patients refractory to
medical therapy remains undefined. In a landmark 1996 New England Journal article, Barker
and colleagues demonstrated that microvascular decompression is safe and effective, with a
high rate of long-term success.15 More recently
a review of ablative procedures found that
radiofrequency thermocoagulation offers the
highest rates of complete pain relief but also the
highest rates of complications (e.g., masticatory weakness, corneal numbness, dysesthesia
(impairment of sensitivity)), when compared
with mechanical balloon, chemical injection,
and radiosurgical ablation techniques.16 The
sole prospective study of Gamma Knife Radiosurgery showed that radiosurgery is a safe and
effective treatment, associated with delayed
pain cessation but fewer complications than
minimally-invasive ablative techniques.17
In practice, treatment decisions are centered
around individual patient and treatment
team characteristics and preferences. Young
patients with TN1-type TN are often excellent
candidates for open surgery, and microvascular
decompression will typically achieve a complete
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cure. Elderly patients with increased medical
risks are often appropriate candidates for ablative therapies, which produce immediate relief.
Finally, for elderly patients willing to wait a few
weeks for symptoms to resolve, radiosurgery is
an ideal choice because of its high efficacy and
low complication profile.

4. Eboli, P., Stone, J. L., Aydin, S. & Slavin, K. V. Historical
characterization of trigeminal neuralgia.Neurosurgery 64,
1183-6; discussion 1186-7 (2009).
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